Allogeneic hematopoietic stem cell transplantation for patients with severe aplastic anemia following nonmyeloablative conditioning using 200-cGy total body irradiation and fludarabine

Biol Blood Marrow Transplant. 2006 Aug;12(8):887-90. doi: 10.1016/j.bbmt.2006.04.005.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Adult
  • Anemia, Aplastic / complications
  • Anemia, Aplastic / mortality
  • Anemia, Aplastic / therapy*
  • Disease-Free Survival
  • Female
  • Follow-Up Studies
  • Graft vs Host Disease / etiology
  • Graft vs Host Disease / mortality
  • Graft vs Host Disease / prevention & control
  • Hematopoietic Stem Cell Transplantation* / mortality
  • Humans
  • Male
  • Middle Aged
  • Myeloablative Agonists / administration & dosage*
  • Peripheral Blood Stem Cell Transplantation* / mortality
  • Remission Induction
  • Retrospective Studies
  • Severity of Illness Index
  • Transplantation Conditioning* / methods
  • Transplantation Conditioning* / mortality
  • Vidarabine / administration & dosage
  • Vidarabine / analogs & derivatives*
  • Whole-Body Irradiation

Substances

  • Myeloablative Agonists
  • Vidarabine
  • fludarabine